Maxalt RPD

Medicinal product

(Invented) name

Maxalt RPD

Active substance (s)

Rizatriptanas

Strength

10 mg

Pharmaceutical form

geriamasis liofilizatas

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N02CC04, Rizatriptan

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2025-10-10

Date of renewal

Documents

2940_Maxalt RPD 10 mg ger liofiliz_PZ.docx

2940_Maxalt RPD 10 mg ger liofiliz_PL.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Geriamajame liofilizate yra:	1 vnt.
Rizatriptanas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
118913	105019	1105019	lizdinė plokštelė	N3		Receptinis	LT/L/25/2940/001	Netiekiama	-	2026-07-01	No	-	-	Download
118914	105020	1105020	lizdinė plokštelė	N6		Receptinis	LT/L/25/2940/002	Netiekiama	-	2026-07-01	No	-	-

Stadijos

Data	Stadija
2025-10-10	Registruotas